Literature DB >> 18804693

Molecular mechanisms of adaptation to folate deficiency.

Ilan Ifergan1, Yehuda G Assaraf.   

Abstract

Folic acid is an essential vitamin for a wide spectrum of biochemical reactions; however, unlike bacteria and plants, mammals are devoid of folate biosynthesis and thus must obtain this cofactor from exogenous sources. Therefore, folate deficiency may impair the de novo biosynthesis of purines and thymidylate and thereby disrupt DNA and RNA metabolism, homocysteine remethylation, methionine biosynthesis, and subsequent formation of S-adenosylmethionine (the universal methyl donor) which in turn may lead to altered methylation reactions. This impaired folate-dependent intracellular metabolism can lead to several key pathologies including, for example, megaloblastic anemia, homocysteinemia, cardiovascular disease, embryonic defects, in particular neural tube defects (NTDs), congenital heart defects, and possibly cancer. The current review presents and evaluates the up-to-date knowledge regarding the molecular mechanisms underlying cellular survival and/or adaptation to folate deficiency or insufficiency. These mechanisms of adaptation to folate deficiency generally associated with folate uptake, intracellular folate retention, folate-dependent metabolism, and active folate efflux specifically include: (a) Up- or downregulation of various folate-dependent enzymes like dihydrofolate reductase (DHFR) and thymidylate synthase (TS), (b) Cellular retention of folates via polyglutamylation by the enzyme folylpoly-gamma-glutamate synthetase (FPGS), (c) Overexpression of folate influx systems including the reduced folate carrier (RFC), folate receptor (FR) as well as the proton-coupled folate transporter (PCFT), a recently identified intestinal folate influx transporter optimally functioning at the acidic microclimate of the upper intestinal epithelium, (d) Downregulation of ATP-driven folate efflux transporters of the multidrug resistance protein (MRP; ABCC) family and breast cancer resistance protein (BCRP; ABCG2) that belong to the multidrug resistance (MDR) efflux transporters of the ATP-binding cassette (ABC) superfamily. Moreover, the intricate interplay between various components of the adaptive response to folate deprivation is also discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804693     DOI: 10.1016/S0083-6729(08)00404-4

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  13 in total

1.  The obligatory intestinal folate transporter PCFT (SLC46A1) is regulated by nuclear respiratory factor 1.

Authors:  Nitzan Gonen; Yehuda G Assaraf
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

Review 2.  Nutrient transport in the mammary gland: calcium, trace minerals and water soluble vitamins.

Authors:  Nicolas Montalbetti; Marianela G Dalghi; Christiane Albrecht; Matthias A Hediger
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-02-25       Impact factor: 2.673

3.  Organic cation uptake is enhanced in bcrp1-transfected MDCKII cells.

Authors:  Guoyu Pan; Tate N Winter; John C Roberts; Carolyn A Fairbanks; William F Elmquist
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

Review 4.  Mechanisms of membrane transport of folates into cells and across epithelia.

Authors:  Rongbao Zhao; Ndeye Diop-Bove; Michele Visentin; I David Goldman
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

Review 5.  Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors.

Authors:  Ignace Vergote; Christopher P Leamon
Journal:  Ther Adv Med Oncol       Date:  2015-07       Impact factor: 8.168

6.  white regulates proliferative homeostasis of intestinal stem cells during ageing in Drosophila.

Authors:  Ayaka Sasaki; Takashi Nishimura; Tomomi Takano; Saki Naito; Sa Kan Yoo
Journal:  Nat Metab       Date:  2021-04-05

7.  Hif1α down-regulation is associated with transposition of great arteries in mice treated with a retinoic acid antagonist.

Authors:  Francesca Amati; Laura Diano; Luisa Campagnolo; Lucia Vecchione; Daria Cipollone; Susana Bueno; Gianluca Prosperini; Alessandro Desideri; Gregorio Siracusa; Giovanni Chillemi; Bruno Marino; Giuseppe Novelli
Journal:  BMC Genomics       Date:  2010-09-16       Impact factor: 3.969

8.  Prelesional arterial endothelial phenotypes in hypercholesterolemia: universal ABCA1 upregulation contrasts with region-specific gene expression in vivo.

Authors:  Mete Civelek; Gregory R Grant; Chrysta R Irolla; Congzhu Shi; Rebecca J Riley; Oscar A Chiesa; Christian J Stoeckert; John W Karanian; William F Pritchard; Peter F Davies
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-06       Impact factor: 4.733

9.  Associations between ABCG2 gene polymorphisms and isolated septal defects in a Han Chinese population.

Authors:  Chuan Wang; Liang Xie; Huaying Li; Yifei Li; Dezhi Mu; Rong Zhou; Ruiqi Liu; Kaiyu Zhou; Yimin Hua
Journal:  DNA Cell Biol       Date:  2014-06-30       Impact factor: 3.311

10.  Folic Acid Impairs the Uptake of 5-Methyltetrahydrofolate in Human Umbilical Vascular Endothelial Cells.

Authors:  Desiree Smith; Jacqueline Hornstra; Monica Rocha; Gerrit Jansen; Yehuda Assaraf; Inbal Lasry; Henk Blom; Yvo M Smulders
Journal:  J Cardiovasc Pharmacol       Date:  2017-10       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.